These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19211501)

  • 21. Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients.
    Gómez HL; Castañeda CA; Vigil CE; Vidaurre T; Velarde RG; Cruz WR; Pinto JA; Suazo JF; Garcés MR; Neciosup SP; Vallejos CS
    Hematol Oncol Stem Cell Ther; 2010; 3(3):109-15. PubMed ID: 20890067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.
    Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H
    Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
    Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
    Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women.
    Kaplan HG; Malmgren JA; Atwood MK
    J Geriatr Oncol; 2013 Apr; 4(2):148-56. PubMed ID: 24071540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer.
    Li Y; Cao J; Zhou Y; Mao F; Shen S; Sun Q
    Sci Rep; 2019 Jul; 9(1):10544. PubMed ID: 31332233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival from operable breast cancer: prognostic factors in Yogyakarta, Indonesia.
    Aryandono T; Harijadi ; Soeripto
    Asian Pac J Cancer Prev; 2006; 7(3):455-9. PubMed ID: 17059344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?
    Pignol JP; Rakovitch E; Olivotto IA
    J Clin Oncol; 2011 Jul; 29(21):2841-3. PubMed ID: 21670459
    [No Abstract]   [Full Text] [Related]  

  • 29. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients.
    Gago FE; Tello OM; Diblasi AM; Ciocca DR
    J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):431-7. PubMed ID: 10030692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.
    Park S; Park BW; Kim TH; Jeon CW; Kang HS; Choi JE; Hwang KT; Kim IC
    Ann Surg Oncol; 2013 May; 20(5):1505-13. PubMed ID: 23192228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy.
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1095-101. PubMed ID: 20638197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer].
    Wang YJ; Wang N; Wang B; Qin WX; Xue CY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):346-50. PubMed ID: 19799082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
    Cefaro GA; Genovesi D; Trignani M; DI Nicola M
    Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
    Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
    Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Young Age in Hormone Receptor Positive Breast Cancer.
    Lee MK; Varzi LA; Chung DU; Cao MA; Gornbein J; Apple SK; Chang HR
    Biomed Res Int; 2015; 2015():325715. PubMed ID: 26351632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36-45 years) breast cancer patients.
    Szollár A; Újhelyi M; Polgár C; Oláh E; Pukancsik D; Rubovszky G; Udvarhelyi N; Kovács T; Sávolt Á; Kenessey I; Mátrai Z
    Eur J Surg Oncol; 2019 Nov; 45(11):2009-2015. PubMed ID: 31189512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of prognostic factors for locally advanced breast cancer.
    Chakrabarti A; Dasgupta P; Haldar D; Acharyya S; Gangopadhyay S
    J Indian Med Assoc; 2012 May; 110(5):284-6. PubMed ID: 23360018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of recurrence in small-sized, node negative breast cancer in young women: a retrospective study in Chinese population.
    Zhang X; Li P; Ma W; Di W; Zhao S; Gao Q; Zhao Y; Yang M; Zhang Q
    Sci China Life Sci; 2013 Apr; 56(4):335-40. PubMed ID: 23483340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.